Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid in Hysteroscopic Myomectomy
NCT03122782Phase 3Unknown
- Sponsor
- Ain Shams University
- Start
- Aug 2017
- Primary completion
- Aug 2017
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial comparing Tranexamic Acid Group with Placebo Group (2 arms). Primary endpoints: Estimated Blood Loss defined as comparing hemoglobin at baseline and 24 hours after surgery and Estimated Blood Loss defined as comparing hematocrit at baseline and 24 hours after surgery. Status: unknown.
02
Drugs
tranexamic acid
Beyond the preview
Go deeper on NCT03122782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03122782.